# Erosive Esophagitis: Developing Drugs for Treatment - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/erosive-esophagitis-developing-drugs-for-treatment/985e94e3-4616-49e9-822e-0854256bb10e

> FDA guidance document: Erosive Esophagitis: Developing Drugs for Treatment. Issue date: September 17, 2025. Get complete insights and analysis.

---

## Details

- Title: Erosive Esophagitis: Developing Drugs for Treatment
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2025-09-17
- Last Changed: 2025-09-16
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2025-D-0346">FDA-2025-D-0346</a>

## Related Documents

- [Erosive Esophagitis: Developing Drugs for Treatment: Draft Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/erosive-esophagitis-developing-drugs-for-treatment-draft-guidance-for-industry/db47ebb5-eadc-4f7b-a236-ac6b016c3ec7)
- [Symptomatic Nonerosive Gastroesophageal Reflux Disease:  Developing Drugs for Treatment: Draft Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/symptomatic-nonerosive-gastroesophageal-reflux-disease-developing-drugs-for-treatment-draft-guidance-for-industry/a7edda76-4160-401c-a7b4-f752b268fd5d)
- [Disseminated Coccidioidomycosis: Developing Drugs for Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/disseminated-coccidioidomycosis-developing-drugs-for-treatment/57566736-a0f1-4c1b-b09c-f05bfb8ce885)